Oxford Biomedica (LON:OXB) Stock Price Crosses Below 200 Day Moving Average – Time to Sell?

Oxford Biomedica plc (LON:OXB) crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 359.21 ($4.82) and traded as low as GBX 299 ($4.01). Oxford Biomedica shares last traded at GBX 303.50 ($4.07), with a volume of 65,557 shares.

Oxford Biomedica Stock Performance

The company has a debt-to-equity ratio of 166.48, a current ratio of 2.35 and a quick ratio of 1.67. The firm has a market cap of £329.53 million, a price-to-earnings ratio of -2.30 and a beta of 1.09. The firm has a fifty day simple moving average of GBX 290.91 and a two-hundred day simple moving average of GBX 359.21.

Oxford Biomedica (LON:OXB) last issued its quarterly earnings results on Wednesday, April 9th. The biopharmaceutical company reported GBX (41.75) (($0.56)) earnings per share for the quarter. Oxford Biomedica had a negative return on equity of 202.50% and a negative net margin of 145.98%. On average, analysts expect that Oxford Biomedica plc will post -31.0799998 EPS for the current year.

About Oxford Biomedica

Oxford Biomedica (LSE: OXB) is a quality and innovation-led cell and gene therapy CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world.

One of the original pioneers in cell and gene therapy, the Company has more than 25 years of experience in viral vectors; the driving force behind the majority of gene therapies.